Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
The inspection closed with five observations which were more of procedural changes with none of these related to data integrity
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Dyslipidemia is a critical risk factor for cardiovascular diseases
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
This strategic decision will unlock significant value for our scientific and industrial products business
Subscribe To Our Newsletter & Stay Updated
